Sickle cell disease (SCD) is a disorder of the red blood cell1,2

Treat the root cause of
sickling with Oxbryta1,2

Empower patients to imagine less sickling by targeting their SCD from the ground up with Oxbryta1,2:

  • The first and only direct hemoglobin S (HbS) polymerization inhibitor
  • A once-daily oral therapy for patients as young as 4 years of age
See how Oxbryta works

Get the latest information about Oxbryta delivered to your inbox